122 related articles for article (PubMed ID: 11072043)
1. Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin.
Sheridan RE; Deshpande SS; Amersdorfer P; Marks JD; Smith T
Toxicon; 2001 May; 39(5):651-7. PubMed ID: 11072043
[TBL] [Abstract][Full Text] [Related]
2. Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin.
Torii Y; Shinmura M; Kohda T; Kozaki S; Takahashi M; Ginnaga A
Toxicon; 2013 Oct; 73():9-16. PubMed ID: 23834917
[TBL] [Abstract][Full Text] [Related]
3. Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin.
Takahashi T; Joshi SG; Al-Saleem F; Ancharski D; Singh A; Nasser Z; Simpson LL
Vaccine; 2009 Apr; 27(19):2616-24. PubMed ID: 19428868
[TBL] [Abstract][Full Text] [Related]
4. Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.
Sepulveda J; Mukherjee J; Tzipori S; Simpson LL; Shoemaker CB
Infect Immun; 2010 Feb; 78(2):756-63. PubMed ID: 19917718
[TBL] [Abstract][Full Text] [Related]
5. Detection of Clostridium botulinum toxin by local paralysis elicited with intramuscular challenge.
Sugiyama H; Brenner SL; Dasgupta BR
Appl Microbiol; 1975 Sep; 30(3):420-3. PubMed ID: 1180550
[TBL] [Abstract][Full Text] [Related]
6. Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.
Torgeman A; Ozeri E; Ben David A; Diamant E; Rosen O; Schwartz A; Barnea A; Makovitzki A; Mimran A; Zichel R
Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28555060
[TBL] [Abstract][Full Text] [Related]
7. An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E.
Li M; Lee D; Obi CR; Freeberg JK; Farr-Jones S; Tomic MT
PLoS One; 2018; 13(5):e0197011. PubMed ID: 29746518
[TBL] [Abstract][Full Text] [Related]
8. Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
Atassi MZ; Dolimbek BZ; Steward LE; Aoki KR
Crit Rev Immunol; 2007; 27(4):319-41. PubMed ID: 18197812
[TBL] [Abstract][Full Text] [Related]
9. Immuno-detection of cleaved SNAP-25 from differentiated mouse embryonic stem cells provides a sensitive assay for determination of botulinum A toxin and antitoxin potency.
Yadirgi G; Stickings P; Rajagopal S; Liu Y; Sesardic D
J Immunol Methods; 2017 Dec; 451():90-99. PubMed ID: 28943257
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo and in vitro mouse bioassays for botulinum toxin antagonists.
Sheridan RE; Deshpande SS; Smith T
J Appl Toxicol; 1999 Dec; 19 Suppl 1():S29-33. PubMed ID: 10594897
[TBL] [Abstract][Full Text] [Related]
11. Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins.
Rosen O; Ozeri E; Barnea A; David AB; Zichel R
Toxins (Basel); 2016 Sep; 8(10):. PubMed ID: 27669303
[TBL] [Abstract][Full Text] [Related]
12. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.
Lou J; Wen W; Conrad F; Meng Q; Dong J; Sun Z; Garcia-Rodriguez C; Farr-Jones S; Cheng LW; Henderson TD; Brown JL; Smith TJ; Smith LA; Cormier A; Marks JD
Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29462889
[TBL] [Abstract][Full Text] [Related]
13. An improved method for development of toxoid vaccines and antitoxins.
Jones RG; Liu Y; Rigsby P; Sesardic D
J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
[TBL] [Abstract][Full Text] [Related]
14. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
[TBL] [Abstract][Full Text] [Related]
16. Detection of antibodies against botulinum toxins.
Sesardic D; Jones RG; Leung T; Alsop T; Tierney R
Mov Disord; 2004 Mar; 19 Suppl 8():S85-91. PubMed ID: 15027059
[TBL] [Abstract][Full Text] [Related]
17. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
Fan KL; Wang YL; Chu G; Leung LP
J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
[TBL] [Abstract][Full Text] [Related]
18. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
[TBL] [Abstract][Full Text] [Related]
19. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.
Kodihalli S; Emanuel A; Takla T; Hua Y; Hobbs C; LeClaire R; O'Donnell DC
PLoS One; 2017; 12(11):e0186892. PubMed ID: 29166654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
